Pending Legislation 2017

Bills that made it through both chambers (April 22, 2017)

HF 524, S-3388: Medical Cannabidiol Act

Notes on HF 524
  1. April 23, 2017 – Letter to Jack Whitver PDF.

Bills that made it through one chamber (April 22, 2017)

SF 506: An Act creating the compassionate use of medical cannabis preparations Act, reclassifying marijuana, including tetrahydrocannabinols, from a schedule I controlled substance to a schedule II controlled substance

Notes on SF 506
  1. April 20, 2017 – Letter to Kevin Koester PDF.
  2. April 19, 2017 – Letter to Guy Vander Linden PDF.
  3. April 16, 2017 – Letter to Jack Whitver PDF.
  4. April 12, 2017 - Senate Appropriations Committee Final Vote: Ayes, 19: Schneider, Kraayenbrink, Bolkcom, Boulton, Chelgren, Danielson, Dotzler, Garrett, Greene, Guth, Hart, C. Johnson, Lofgren, Mathis, McCoy, Ragan, Rozenboom, Shipley, and Zumbach. Nays, 1: Costello. Absent, 1: Bertrand. S.J. 1001 PDF
  5. April 13, 2017 - Senate Ways and Means Committee Final Vote: Ayes, 14: Feenstra, Behn, Jochum, Anderson, Bolkcom, Breitbach, Brown, Dotzler, Edler, McCoy, Petersen, Quirmbach, Schultz, and Smith. Nays, 1: Dawson. Absent, none. S.J. 1019 PDF
  6. April 17, 2017 - Senate Final Vote: Ayes, 45; Nays, 5: Bowman, Brietbach, Costello, Dawson, Garrett; Absent, none. S.J. 1037 PDF

Bills that made it through the second funnel (March 31, 2017)

HF 520: An Act relating to the medical use of cannabidiol including the rescheduling of a cannabidiol investigational product approved as a prescription drug medication under federal law

Notes on HF 520
  1. requires the Iowa Board of Pharmacy to reclassify a cannabidiol product if the federal government places it in another schedule
  2. repeals the expiration date of the Iowa Medical Cannabidiol Act
  3. April 21, 2017 – Letter to Kevin Koester PDF.
  4. April 3, 2017 – Letter to Kevin Koester PDF.
  5. March 12, 2017 – Letter to Kevin Koester PDF.
  6. March 4, 2017 – Letter to Kevin Koester PDF.
  7. February 26, 2017 – Letters to Subcommittee Members: Jarad Klein PDF, Kristi Hager PDF, Bob Kressig PDF.
  8. February 27, 2017 – Letter to Subcommittee Member: Kristi Hager PDF.
  9. February 28, 2017 – Letter to Subcommittee Member: Kristi Hager PDF.
  10. February 28, 2017 – Letter to Subcommittee Member: Jarad Klein PDF.

SF 470: An Act relating to the medical use of cannabidiol including the rescheduling of a cannabidiol investigational product approved as a prescription drug medication under federal law

Notes on SF 470
  1. April 3, 2017 – Letter to Jack Whitver PDF.
  2. March 18, 2017 – Letter to Jack Whitver PDF.
  3. March 4, 2017 – Letter to Jack Whitver PDF.
  4. February 20, 2017 – Letter to Andrew Funk PDF
  5. February 19, 2017 – Letter to Andrew Funk PDF
  6. requires the Iowa Board of Pharmacy to reclassify a cannabidiol product if the federal government places it in another schedule
  7. repeals the expiration date of the Iowa Medical Cannabidiol Act
  8. February 22, 2017 – Letters to Subcommittee Members: Brad Zaun PDF, Tom Shipley PDF, Tony Bisignano PDF.

Bills that made it through the funnel (March 3, 2017)

SF 432: An Act relating to the possession of marijuana

Notes on SF 432
  1. reduces the penalty for 5 grams or less to a simple misdemeanor for the first offense
  2. simple misdemeanor is defined in Iowa Code § 903.1(1)(a) (2017)

Bills that did not make it through the funnel (March 3, 2017)

SSB 1176: An Act creating the compassionate use of medical cannabis preparations Act, reclassifying marijuana, including tetrahydrocannabinols, from a schedule I controlled substance to a schedule II controlled substance

Notes on SSB 1176
  1. reclassifies marijuana and tetrahydrocannabinols (page 1)
  2. thirteen medical conditions to start, department can add more later (page 2)
  3. plants and preparations can have no more than 10% THC by weight (page 4)
  4. doctor certifies the diagnosis, but does not make a recommendation (pages 4-5)
  5. fee of $100 ($25 for disabled) (page 6)
  6. four manufacturers to start, department can add more later (page 9)
  7. twelve dispensaries to start, department can add more later (page 12)

HSB 159: An Act relating to the medical use of cannabidiol including the rescheduling of a cannabidiol investigational product approved as a prescription drug medication under federal law

Notes on HSB 159
  1. requires the Iowa Board of Pharmacy to reclassify cannabidiol product if the federal government reschedules it
  2. February 26, 2017 – Letter to Subcommittee Member: Joel Fry PDF.

HSB 132: An Act relating to the medical cannabidiol Act, making related modifications

Notes on HSB 132
  1. This bill makes Iowa Code Chapter 124D PDF (the “Medical Cannabidiol Act”) permanent (the current chapter expires at the end of June 2017)
  2. The bill provides for the production of cannabis in Iowa to make cannabidiol
  3. The University of Iowa medical school can recommend additional conditions which cannabidiol can be used to treat
  4. February 21, 2017 – Letters to Subcommittee Members: Jarad Klein PDF, Kristi Hager PDF, Bob Kressig PDF.

SF 266: An Act relating to marijuana and cannabidiol by modifying penalties and creating a drug court revolving fund.

Notes on SF 266
  1. one ounce or less: $50 for first offense; $100 for second offense; $200 for third and subsequent offense
  2. more than one ounce: six months / $1000 for first offense; Iowa Code § 903.1(1)(b) (2017) for second offense; aggravated misdemeanor for third and subsequent offense
  3. no loss of drivers license; no forfeiture for one ounce or less

SF 205: Medical Cannabis Act, Reclassifying Marijuana, Including Tetrahydrocannabinols, from schedule I to schedule II

Notes on SF 205
  1. February 6, 2017 – Letter to Sen. Jack Whitver PDF
  2. removes cannabis from schedule 1 and places it in schedule 2 (page 1, line 1)
  3. department can add medical conditions (page 3, line 1)
  4. practitioner only determines diagnosis and certifies it (page 4, line 2)
  5. $100 for registration card ($25 for some) (page 5, line 13)
  6. department picks advisory council (page 7, line 2)
  7. manufacturer license fee of $7500 (page 9, line 14)
  8. some reciprocity (page 16, line 21)

HF 199: Medical Cannabis Act, Reclassifying Marijuana, Including Tetrahydrocannabinols, from schedule I to schedule II

Notes on HF 199
  1. February 3, 2017 – Letter to Rep. Kevin Koester PDF
  2. removes cannabis from schedule 1 and places it in schedule 2 (page 1, line 1)
  3. department can add medical conditions (page 3, line 2)
  4. licensed growers can be for-profit organizations (page 3, line 5)
  5. licensed distributors can be for-profit organizations (page 3, line 9)
  6. practitioner only determines the diagnosis and certifies it (page 4, line 30)
  7. $100 for registration card ($25 for some) (page 5, line 34)
  8. department picks advisory council (page 7, line 23)
  9. manufacture license $7500 (page 10, line 1)
  10. some reciprocity (page 17, line 3)

HF 198: Medical Cannabis Act

Notes on HF 198
  1. personal growing (page 1, line 4)
  2. three month supply (page 1, line 27)
  3. department can add medical conditions (page 2, line 15)
  4. licensed growers can be personal growers or non-profit organizations (page 2, line 17)
  5. practitioner determines benefit outweighs risk (page 3, line 22)
  6. intrastate only (page 6, line 22)
  7. iowa medical society picks advisory council (page 6, line 35)
  8. talks about a fee but does not specify an amount